ライフサイエンスコーパス: poliomyelitis

1 P assembly may be shared features of SMA and poliomyelitis.

2 ing the risk of vaccine-associated paralytic poliomyelitis.

3 s, encephalitis, and acute flaccid paralysis/poliomyelitis.

4 part of the worldwide campaign to eradicate poliomyelitis.

5 causes a paralytic condition consistent with poliomyelitis.

6 t with a viral encephalomyelitis, similar to poliomyelitis.

7 ing intramuscular injections and provocation poliomyelitis.

8 by the age distribution of the children with poliomyelitis.

9 valuated for induced immunity against type 3 poliomyelitis.

10 an Health Organization as cases of suspected poliomyelitis.

11 imates of the efficacy of these OPVs against poliomyelitis.

12 inate vaccine-associated and vaccine-derived poliomyelitis.

13 otection from paralysis in a murine model of poliomyelitis.

14 al oral human infection leading to paralytic poliomyelitis.

15 elerate eradication and prevent outbreaks of poliomyelitis.

16 alth Assembly resolved to globally eradicate poliomyelitis.

17 on of safety in primate models for paralytic poliomyelitis.

18 and associated increases in the incidence of poliomyelitis.

19 revert to neurovirulence and cause paralytic poliomyelitis.

20 cts of individuals with laboratory-confirmed poliomyelitis, 27 (12.7%) of 213 and 29 (13.9%) of 209 h

21 31, 2011, there were 883 cases of serotype 1 poliomyelitis (710 in Pakistan and 173 in Afghanistan) a

22 Poliovirus (PV) is the causative agent of poliomyelitis, a crippling human disease known since ant

23 e and cause paralytic disease (age-dependent poliomyelitis [ADPM]).

24 eptor (PVR) gene (TgPVR mice), which develop poliomyelitis after intracerebral inoculation, are not s

25 637 days without developing any symptoms of poliomyelitis, after which excretion appeared to have ce

26 rted number of doses received by people with poliomyelitis and by matched controls as identified in N

27 Health (MOH), national surveillance data for poliomyelitis and charts of cases at the national rehabi

28 myelitis due to vaccine-associated paralytic poliomyelitis and circulating vaccine-derived poliovirus

29 for paralytic polio in an animal system for poliomyelitis and have determined the pathogenic mechani

30 Recent American successes against poliomyelitis and measles have been attributed to repeat

31 quantitatively assessed the epidemiology of poliomyelitis and programme performance and considered t

32 case was defined as a diagnosis of paralytic poliomyelitis and residual paralysis at 60 days in a pat

33 ent oral poliovirus vaccine (OPV) to prevent poliomyelitis and the season when children were vaccinat

34 were collected from children with confirmed poliomyelitis and were used to assess correlates of vacc

35 uropathogenic potential in animal models for poliomyelitis and, at a very low rate, they can cause po

36 , meningitis, septicemia, herpes zoster, and poliomyelitis), and inflammatory (glomerulonephritis, ne

37 er's first surveillance systems for malaria, poliomyelitis, and influenza.

38 gic principles for the global eradication of poliomyelitis are as follows: Poliovirus causes acute, n

39 because oral polio vaccine can rarely cause poliomyelitis as it mutates and may fail to provide adeq

40 From 1988 to 1993, 30 cases of poliomyelitis associated with poliovirus type 2 were fou

41 surveillance data recording the presence of poliomyelitis associated with wild-type 1 poliovirus in

42 ely correlated with the probability of VDPV2 poliomyelitis being reported in a district.

43 pinal cord anterior horn cells; thus, severe poliomyelitis, but not acute encephalitis, was observed

44 Despite substantial efforts to eradicate poliomyelitis by administering oral poliovirus vaccine t

45 e individually matched with children who had poliomyelitis by age, sex, and residence.

46 o the PV receptor (PVR) and causes paralytic poliomyelitis by replicating within motor neurons of the

47 be chronically infected with poliovirus, and poliomyelitis can develop despite treatment with intrave

48 Sabin vaccine strains used in prevention of poliomyelitis carry such mutations in their IRES element

49 We estimate from the poliomyelitis case count and the paralytic case-to-infec

50 The last imported poliomyelitis case occurred in 1993 and the last case of

51 rgency protection of contacts of a paralytic poliomyelitis case.

52 io, Pakistan bears the highest proportion of poliomyelitis cases among the 3 endemic countries includ

53 us and reasons for undervaccination among 66 poliomyelitis cases and 130 age- and neighborhood-matche

54 After 25 years without poliomyelitis cases caused by circulating wild polioviru

55 d lead to roughly 200 000 expected paralytic poliomyelitis cases every year in low-income countries,

56 Fatal poliomyelitis cases gave laboratory evidence of previous

57 to detect WPV circulation in the absence of poliomyelitis cases in many communities.

58 demicity, 1900-1950, the age distribution of poliomyelitis cases increased gradually.

59 , which is consistent with recent absence of poliomyelitis cases; whereas seroprevalence against type

60 An epidemic of poliomyelitis caused by poliovirus type 1 occurred in Th

61 hed case-control pairs of confirmed cases of poliomyelitis caused by type 1 wild poliovirus and cases

62 Available literature on outbreaks of poliomyelitis caused by wild polioviruses between 1996 a

63 The global eradication of poliomyelitis caused by wild-type virus is likely to be

64 for the Certification of the Eradication of Poliomyelitis certified the eradication of type 2 poliov

65 This phenomenon, labeled "provocation poliomyelitis," continues to cause numerous cases of chi

66 irus vaccines led to a stepwise reduction in poliomyelitis, culminating in the unpredicted eliminatio

67 The odds of observing poliomyelitis decreased with improved routine or supplem

68 one of the compounds in an in vivo model of poliomyelitis demonstrated partial protection from the o

69 st three times more effective against type 1 poliomyelitis disease than is trivalent vaccine.

70 Five cases of poliomyelitis due to type 2 or 3 recombinant vaccine-der

71 accine (OPV) results in an ongoing burden of poliomyelitis due to vaccine-associated paralytic poliom

72 The last patient with poliomyelitis due to wild poliovirus in the Americas had

73 igated; none has been confirmed as paralytic poliomyelitis due to wild poliovirus.

74 stigations included the study of the Buffalo poliomyelitis epidemic of 1912, by Wade Hampton Frost, w

75 sion for the Certification of Eradication of Poliomyelitis Eradication (ICCPE) was established by the

76 national Commission for the Certification of Poliomyelitis Eradication declared the Americas to be po

77 years are a critical component of the global poliomyelitis eradication effort.

78 ay become relevant during the final phase of poliomyelitis eradication in populations with predominan

79 Regional Commission for the Certification of Poliomyelitis Eradication in the Western Pacific certifi

80 resolution on intensification of the Global Poliomyelitis Eradication Initiative (GPEI), the Nigeria

81 The completion of poliomyelitis eradication is a global emergency for publ

82 veloping "endgame" strategies for the Global Poliomyelitis Eradication Program.

83 ental surveillance (ES) of poliovirus in the poliomyelitis eradication strategic plan as an activity

84 ed data on 2296 cases of GBS reported to the Poliomyelitis Eradication Surveillance System of the Pan

85 The "endgame" for worldwide poliomyelitis eradication will entail eventual cessation

86 Focusing on the large costs for poliomyelitis eradication, without assessing the even la

87 of combined diphtheria-tetanus-pertussis and poliomyelitis expanded vaccines with the first of three

88 duced population immunity against serotype-2 poliomyelitis for 1 January 2004-30 June 2015 and produc

89 minate vaccine-associated or vaccine-derived poliomyelitis from serotype 2 poliovirus.

90 erica as part of the initiative to eradicate poliomyelitis from the Western Hemisphere.

91 cases of paralysis often in countries where poliomyelitis had not occurred for many years.

92 Poliomyelitis has appeared in epidemic form, become ende

93 Although poliomyelitis has been mostly eradicated worldwide, larg

94 The number of cases of paralytic poliomyelitis has declined in Nigeria since the introduc

95 This investigation confirms that poliomyelitis has remained endemic in Angola since indep

96 Moreover, several outbreaks of poliomyelitis have been shown to be caused by viruses de

97 likely to protect >80% of recipients against poliomyelitis if poliovirus reemerges after withdrawal o

98 ation, having contributed to 73% of reported poliomyelitis in 2015 and 54% in 2016.

99 to detect poliovirus infections or paralytic poliomyelitis in Amish communities in Minnesota, neighbo

100 on is evidenced by the documented absence of poliomyelitis in an increasing number of countries and t

101 Control of poliomyelitis in Angola is essential to expand the polio

102 of HEV-C may share PV's potential to elicit poliomyelitis in humans.

103 e the key factors sustaining transmission of poliomyelitis in Nigeria and to calculate clinical effic

104 ine immunization was a major risk factor for poliomyelitis in Pakistan.

105 iated with fatal outcomes among persons with poliomyelitis in Pointe Noire.

106 e likelihood of vaccine-associated paralytic poliomyelitis in recipients of live attenuated polioviru

107 The last case of poliomyelitis in the United States due to indigenously a

108 The increasing incidence of poliomyelitis in these countries during 2010-11 led the

109 itis and, at a very low rate, they can cause poliomyelitis in vaccine recipients.

110 Six-month forecasts of poliomyelitis incidence by district for 2013-2016 showed

111 rns are important determinants of historical poliomyelitis incidence in Pakistan; however, movement d

112 Reasons for continued high poliomyelitis incidence include failure to vaccinate, va

113 (radiation) was a significant determinant of poliomyelitis incidence, it did not improve the predicti

114 erion [AIC]) to produce 6-month forecasts of poliomyelitis incidence.

115 lenges to the final eradication of paralytic poliomyelitis include the continued transmission of wild

116 erve as a possible determinant of widespread poliomyelitis infection in Pakistan and further emphasiz

117 In contrast to measles, smallpox and poliomyelitis, influenza is caused by viruses that under

118 Poliomyelitis is a highly infectious disease caused by P

119 Poliomyelitis is a highly infectious disease caused by p

120 om a child with vaccine-associated paralytic poliomyelitis is described.

121 recapitulates human poliovirus infection and poliomyelitis, it can be used to study polio pathogenesi

122 recapitulates human poliovirus infection and poliomyelitis, it can be used to study polio pathogenesi

123 t patients with vaccine-associated paralytic poliomyelitis (iVAPP), cases reported in the United Stat

124 The Pan American Regional Poliomyelitis Laboratory Network, developed to support t

125 foot, and mouth disease, aseptic meningitis, poliomyelitis-like acute flaccid paralysis, brainstem en

126 ad meningitis, 8 had encephalitis, and 3 had poliomyelitis-like acute flaccid paralysis.

127 as WNV-infected humans can also experience a poliomyelitis-like disease where motor neurons are damag

128 t ever outbreak of West Nile encephalitis; a poliomyelitis-like flaccid paralysis due to West Nile vi

129 rological diseases, such as encephalitis and poliomyelitis-like paralysis.

130 long-term outcome, although an irreversible poliomyelitis-like syndrome may result.

131 The pathogenic mechanism of provocation poliomyelitis may differ from that of polio acquired in

132 04) data for diphtheria, pertussis, tetanus, poliomyelitis, measles, mumps, rubella (including congen

133 r 1991 and March 1992, 37 cases of paralytic poliomyelitis occurred in Jordan, where none had been re

134 An outbreak of paralytic poliomyelitis occurred in the Dominican Republic (13 con

135 ination against diphtheria-tetanus-pertussis-poliomyelitis (OR = 1.5) and was not statistically signi

136 Since 2005, a large poliomyelitis outbreak associated with type 2 circulatin

137 A poliomyelitis outbreak caused by type 1 circulating vacc

138 A paralytic poliomyelitis outbreak occurred in Namibia in 2006, almo

139 sights into the dynamics of future potential poliomyelitis outbreaks and in this way serve as a usefu

140 ulating vaccine-derived PVs that have caused poliomyelitis outbreaks in different parts of the world.

141 rd eradication of poliomyelitis, the risk of poliomyelitis outbreaks resulting from virus importation

142 cine-derived poliovirus (VDPV), which causes poliomyelitis outbreaks similar to those caused by wild

143 vaccine-derived poliovirus (VDPV) and cause poliomyelitis outbreaks.

144 ssed their association with the incidence of poliomyelitis over time in seven regions of Afghanistan

145 olates obtained over a 337-day period from a poliomyelitis patient from Taiwan with common variable i

146 olates obtained over a 189-day period from a poliomyelitis patient with common variable immunodeficie

147 e-derived isolates from an immunocompromised poliomyelitis patient, the contacts, and the local sewag

148 Poliomyelitis patients admitted to Angola's main pediatr

149 recombinant polioviruses were isolated from poliomyelitis patients in China from 1991 to 1993.

150 phtheria, tetanus, and pertussis (DTP3); and poliomyelitis (polio3)--as dependent variables.

151 s from cases of vaccine-associated paralytic poliomyelitis related to the CHAT vaccine revealed genet

152 Poliomyelitis remains a global threat despite availabili

153 contact with 2761 individuals with suspected poliomyelitis reported during the period 2003-2008.

154 rus has caused meningitis, encephalitis, and poliomyelitis, resulting in significant morbidity and mo

155 offs among different strategies for managing poliomyelitis risks after they succeed with polio eradic

156 e the success of current vaccination against poliomyelitis, safe, cheap and effective vaccines remain

157 tan and 173 in Afghanistan) and 272 cases of poliomyelitis serotype 3 (216 in Pakistan and 56 in Afgh

158 lateral sclerosis or West Nile Virus-induced poliomyelitis, suggesting a common tissue injury pathway

159 e substantial progress toward eradication of poliomyelitis, the risk of poliomyelitis outbreaks resul

160 persons (iVDPV) presents a personal risk of poliomyelitis to the patient as well as a programmatic r

161 ous population immunity continued to support poliomyelitis transmission in Nigeria at the end of 2012

162 -to introduce at least 1 dose of inactivated poliomyelitis vaccine (IPV); withdraw oral poliomyelitis

163 d poliomyelitis vaccine (IPV); withdraw oral poliomyelitis vaccine (OPV), starting with the type 2 co

164 oradic cases of vaccine-associated paralytic poliomyelitis (VAPP) and the emergence of genetically di

165 f patients with vaccine-associated paralytic poliomyelitis (VAPP) in Hungary during 1961-1981 were re

166 e rare cases of vaccine-associated paralytic poliomyelitis (VAPP) in OPV recipients and their close c

167 Vaccine-associated paralytic poliomyelitis (VAPP) is a rare adverse event associated

168 e of 9 cases of vaccine-associated paralytic poliomyelitis (VAPP) were confirmed each year from 1961

169 development of vaccine-associated paralytic poliomyelitis (VAPP).

170 onjunction with vaccine-associated paralytic poliomyelitis (VAPP).

171 ons, leading to vaccine-associated paralytic poliomyelitis (VAPP).

172 f a dose of trivalent OPV against serotype 1 poliomyelitis was 12.5% (95% CI 5.6-18.8) compared with

173 poliovirus vaccine against type 3 paralytic poliomyelitis was 18% (95% CI, 9 to 26).

174 The vaccination history of children with poliomyelitis was compared with that of children with ac

175 Immunity against serotype-2 poliomyelitis was forecasted to improve in April 2016 co

176 The ensuing outbreak of poliomyelitis was investigated: Patients with poliomyeli

177 poliovirus vaccine against type 1 paralytic poliomyelitis were 67% (95% confidence interval [CI], 39

178 oliomyelitis was investigated: Patients with poliomyelitis were evaluated, the extent of poliovirus c

179 Children with poliomyelitis were more likely to have received doses in

180 rom 1990 through 1999, 61 cases of paralytic poliomyelitis were reported; 59 (97%) of these were VAPP

181 PV cause poliomyelitis, whereas CAV21 shares a receptor and a pro

182 therefore be used in eradicating serotype 1 poliomyelitis whilst minimising the risks of serotype 3

183 e vaccinated, 46 children 1-7 years old with poliomyelitis who had received three card-documented dos

184 During 1976-1995, 48 outbreaks of paralytic poliomyelitis with a cumulative total of approximately 1

185 on and presents a disease pattern resembling poliomyelitis with seasonal epidemics that include cases

186 In 2010, a large outbreak of poliomyelitis with unusual 47% lethality occurred in Poi

187 transmission of wild polioviruses (WPVs) and poliomyelitis, with the last case of WPV type 2 in the w

188 viduals was associated with the incidence of poliomyelitis, with the radiation model of movement prov

189 ic phenotype in a transgenic mouse model for poliomyelitis without diminishing the growth properties

190 A mean of 86 cases of poliomyelitis/year were reported in Angola during 1989-1